- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 39/21 - Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic part, with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
Patent holdings for IPC class C07C 39/21
Total number of patents in this class: 131
10-year publication summary
|
10
|
10
|
11
|
6
|
6
|
7
|
2
|
9
|
18
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Versitech Limited | 336 |
6 |
| Colgate-Palmolive Company | 5752 |
5 |
| Bagi Research Limited | 15 |
4 |
| Uha Mikakuto Co., Ltd. | 37 |
4 |
| Kynan Duke IP, LLC | 9 |
4 |
| Thederma Shanghai Co., Ltd. | 16 |
4 |
| Shin-Etsu Chemical Co., Ltd. | 6063 |
3 |
| Hong Kong Baptist University | 119 |
3 |
| Morinaga & Co., Ltd. | 120 |
3 |
| The Trustees of the University of Pennsylvania | 4410 |
2 |
| JSR Corporation | 2551 |
2 |
| ELC Management LLC | 1155 |
2 |
| Laboratorios Senosiain S.A. de C.V. | 17 |
2 |
| Mitsubishi Gas Chemical Company, Inc. | 3620 |
2 |
| Purapharm International (H.K.) Limited | 8 |
2 |
| Taro Pharmaceutical Industries Ltd. | 59 |
2 |
| Teva Pharmaceuticals International GmbH | 319 |
2 |
| Caliway Biopharmaceuticals Co., Ltd. | 21 |
2 |
| Resolvex Pharmaceuticals Inc. | 5 |
2 |
| Chengdu Jinrui Foundation Biotech Co., Ltd. | 16 |
2 |
| Other owners | 73 |